Literature DB >> 10752699

Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

F H Messerli1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752699     DOI: 10.1016/s0140-6736(00)00092-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors:  F Dunne; M J Kendall; U Martin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.

Authors:  Gerald W Smetana
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

3.  Initial treatment of hypertension and adherence to therapy in general practice in Italy.

Authors:  Elisabetta Poluzzi; Petar Strahinja; Antonio Vargiu; Giacomo Chiabrando; Maria Chiara Silvani; Domenico Motola; Giulia Sangiorgi Cellini; Alberto Vaccheri; Fabrizio De Ponti; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2005-08-05       Impact factor: 2.953

Review 4.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

Review 5.  Increasing physical activity for the treatment of hypertension: a systematic review and meta-analysis.

Authors:  Thomas Semlitsch; Klaus Jeitler; Lars G Hemkens; Karl Horvath; Eva Nagele; Christoph Schuermann; Nicole Pignitter; Kirsten H Herrmann; Siw Waffenschmidt; Andrea Siebenhofer
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

6.  Implications of recent hypertension trials for the generalist physician: whom do we treat, and how?

Authors:  Lee Green
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.